173 related articles for article (PubMed ID: 30562171)
1. HIV latency can be established in proliferating and nonproliferating resting CD4+ T cells in vitro: implications for latency reversal.
Moso MA; Anderson JL; Adikari S; Gray LR; Khoury G; Chang JJ; Jacobson JC; Ellett AM; Cheng WJ; Saleh S; Zaunders JJ; Purcell DFJ; Cameron PU; Churchill MJ; Lewin SR; Lu HK
AIDS; 2019 Feb; 33(2):199-209. PubMed ID: 30562171
[TBL] [Abstract][Full Text] [Related]
2. Establishment and Reversal of HIV-1 Latency in Naive and Central Memory CD4+ T Cells In Vitro.
Zerbato JM; Serrao E; Lenzi G; Kim B; Ambrose Z; Watkins SC; Engelman AN; Sluis-Cremer N
J Virol; 2016 Sep; 90(18):8059-73. PubMed ID: 27356901
[TBL] [Abstract][Full Text] [Related]
3. Limitations of dual-fluorescent HIV reporter viruses in a model of pre-activation latency.
Kim Y; Cameron PU; Lewin SR; Anderson JL
J Int AIDS Soc; 2019 Dec; 22(12):e25425. PubMed ID: 31855322
[TBL] [Abstract][Full Text] [Related]
4. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
5. Myeloid Dendritic Cells Induce HIV Latency in Proliferating CD4
Kumar NA; van der Sluis RM; Mota T; Pascoe R; Evans VA; Lewin SR; Cameron PU
J Immunol; 2018 Sep; 201(5):1468-1477. PubMed ID: 30030324
[TBL] [Abstract][Full Text] [Related]
6. Lymphatic endothelial cells promote productive and latent HIV infection in resting CD4+ T cells.
Schilthuis M; Verkaik S; Walhof M; Philipose A; Harlow O; Kamp D; Kim BR; Shen A
Virol J; 2018 Oct; 15(1):152. PubMed ID: 30285810
[TBL] [Abstract][Full Text] [Related]
7. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
[TBL] [Abstract][Full Text] [Related]
8. Reactivation of latent HIV-1 in latently infected cells by coumarin compounds: Hymecromone and ScoparoneReactivation of Latent HIV-1 in Latently Infected Cells by Coumarin Compounds: Hymecromone and Scoparone.
Li X; Zeng H; Wang P; Lin L; Liu L; Zhen P; Fu Y; Lu P; Zhu H
Curr HIV Res; 2016; 14(6):484-490. PubMed ID: 27697031
[TBL] [Abstract][Full Text] [Related]
9. HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.
Chan CN; Trinité B; Lee CS; Mahajan S; Anand A; Wodarz D; Sabbaj S; Bansal A; Goepfert PA; Levy DN
Retrovirology; 2016 Jan; 13():1. PubMed ID: 26728316
[TBL] [Abstract][Full Text] [Related]
10. Entry of Polarized Effector Cells into Quiescence Forces HIV Latency.
Dobrowolski C; Valadkhan S; Graham AC; Shukla M; Ciuffi A; Telenti A; Karn J
mBio; 2019 Mar; 10(2):. PubMed ID: 30914509
[TBL] [Abstract][Full Text] [Related]
11. The role of tumor cells in the modification of T lymphocytes activity--the expression of the early CD69+, CD71+ and the late CD25+, CD26+, HLA/DR+ activation markers on T CD4+ and CD8+ cells in squamous cell laryngeal carcinoma. Part I.
Starska K; Głowacka E; Kulig A; Lewy-Trenda I; Bryś M; Lewkowicz P
Folia Histochem Cytobiol; 2011; 49(4):579-92. PubMed ID: 22252752
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclin T1 during HIV replication and latency establishment in human memory CD4 T cells.
Couturier J; Orozco AF; Liu H; Budhiraja S; Siwak EB; Nehete PN; Sastry KJ; Rice AP; Lewis DE
Virol J; 2019 Feb; 16(1):22. PubMed ID: 30786885
[TBL] [Abstract][Full Text] [Related]
13. In neonates with vitamin D deficiency, low lymphocyte activation markers are risk factors for infection.
Youssef MAM; Zahran AM; Hussien AM; Elsayh KI; Askar EA; Farghaly HS
Paediatr Int Child Health; 2019 May; 39(2):111-118. PubMed ID: 30375272
[No Abstract] [Full Text] [Related]
14. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
[TBL] [Abstract][Full Text] [Related]
15. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
[TBL] [Abstract][Full Text] [Related]
16. Programmed cell death-1 contributes to the establishment and maintenance of HIV-1 latency.
Evans VA; van der Sluis RM; Solomon A; Dantanarayana A; McNeil C; Garsia R; Palmer S; Fromentin R; Chomont N; Sékaly RP; Cameron PU; Lewin SR
AIDS; 2018 Jul; 32(11):1491-1497. PubMed ID: 29746296
[TBL] [Abstract][Full Text] [Related]
17. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Badia R; Ballana E; Castellví M; García-Vidal E; Pujantell M; Clotet B; Prado JG; Puig J; Martínez MA; Riveira-Muñoz E; Esté JA
Nat Commun; 2018 Jul; 9(1):2739. PubMed ID: 30013105
[TBL] [Abstract][Full Text] [Related]
18. Excessive expressions of T cell activation markers in pediatric immune thrombocytopenia.
Chen Y; Zhou Y; Chen P; Zhang P; Jia M; Tang Y
Thromb Res; 2019 Aug; 180():1-9. PubMed ID: 31146120
[TBL] [Abstract][Full Text] [Related]
19. HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κB.
Saleh S; Lu HK; Evans V; Harisson D; Zhou J; Jaworowski A; Sallmann G; Cheong KY; Mota TM; Tennakoon S; Angelovich TA; Anderson J; Harman A; Cunningham A; Gray L; Churchill M; Mak J; Drummer H; Vatakis DN; Lewin SR; Cameron PU
Retrovirology; 2016 Jul; 13(1):49. PubMed ID: 27459960
[TBL] [Abstract][Full Text] [Related]
20. Infection of CD8+ T lymphocytes with HIV. Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells.
De Maria A; Pantaleo G; Schnittman SM; Greenhouse JJ; Baseler M; Orenstein JM; Fauci AS
J Immunol; 1991 Apr; 146(7):2220-6. PubMed ID: 1706390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
